Sangamo Therapeutics, Inc.
ENZYMATIC ASSAYS FOR QUANTIFYING THERAPY IN SUBJECTS WITH MUCOPOLYSACCHARIDOSIS TYPE I OR II
Last updated:
Abstract:
Described herein are enzymatic assays for assessing in vivo therapy of MPSII (Hunter) or MPSI (Hurler) subjects.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2019
Issue date:
5 Mar 2020